nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—CYP2D6—Hydroxyurea—psoriasis	0.141	0.162	CbGbCtD
Yohimbine—CYP3A4—Calcitriol—psoriasis	0.105	0.121	CbGbCtD
Yohimbine—CYP2D6—Cholecalciferol—psoriasis	0.0853	0.0981	CbGbCtD
Yohimbine—CYP3A4—Methoxsalen—psoriasis	0.0819	0.0942	CbGbCtD
Yohimbine—CYP2D6—Cyclosporine—psoriasis	0.056	0.0645	CbGbCtD
Yohimbine—CYP3A4—Cholecalciferol—psoriasis	0.0542	0.0624	CbGbCtD
Yohimbine—CYP3A4—Mycophenolate mofetil—psoriasis	0.047	0.0541	CbGbCtD
Yohimbine—CYP3A4—Triamcinolone—psoriasis	0.047	0.0541	CbGbCtD
Yohimbine—CYP3A4—Betamethasone—psoriasis	0.0403	0.0464	CbGbCtD
Yohimbine—CYP3A4—Prednisolone—psoriasis	0.0398	0.0458	CbGbCtD
Yohimbine—CYP3A4—Hydrocortisone—psoriasis	0.0377	0.0434	CbGbCtD
Yohimbine—CYP3A4—Prednisone—psoriasis	0.0376	0.0432	CbGbCtD
Yohimbine—CYP2D6—Dexamethasone—psoriasis	0.0369	0.0425	CbGbCtD
Yohimbine—CYP3A4—Cyclosporine—psoriasis	0.0356	0.041	CbGbCtD
Yohimbine—Rescinnamine—ACE—psoriasis	0.0247	1	CrCbGaD
Yohimbine—CYP3A4—Dexamethasone—psoriasis	0.0235	0.027	CbGbCtD
Yohimbine—HTR1F—Signaling Pathways—APOE—psoriasis	6.18e-05	0.000582	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR ligand binding—CXCL8—psoriasis	6.15e-05	0.000579	CbGpPWpGaD
Yohimbine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	6.13e-05	0.000577	CbGpPWpGaD
Yohimbine—DRD2—Circadian rythm related genes—IL6—psoriasis	5.96e-05	0.000561	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—NDUFA5—psoriasis	5.95e-05	0.00056	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CARM1—psoriasis	5.8e-05	0.000546	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—NFKBIA—psoriasis	5.76e-05	0.000542	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCL20—psoriasis	5.7e-05	0.000537	CbGpPWpGaD
Yohimbine—DRD2—GPCR ligand binding—CXCL8—psoriasis	5.67e-05	0.000534	CbGpPWpGaD
Yohimbine—HTR2A—GPCR ligand binding—CXCL8—psoriasis	5.58e-05	0.000525	CbGpPWpGaD
Yohimbine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	5.56e-05	0.000523	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—SOCS1—psoriasis	5.35e-05	0.000504	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—SOCS1—psoriasis	5.24e-05	0.000494	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—TYK2—psoriasis	5.11e-05	0.000481	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR ligand binding—CXCL8—psoriasis	5.08e-05	0.000478	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CYP2S1—psoriasis	5.06e-05	0.000476	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—TYK2—psoriasis	5e-05	0.000471	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—SOCS1—psoriasis	4.93e-05	0.000464	CbGpPWpGaD
Yohimbine—HTR1D—GPCR downstream signaling—CXCL8—psoriasis	4.9e-05	0.000461	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—VEGFA—psoriasis	4.86e-05	0.000458	CbGpPWpGaD
Yohimbine—HTR1B—GPCR downstream signaling—CXCL8—psoriasis	4.79e-05	0.000451	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—TYK2—psoriasis	4.72e-05	0.000444	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—TYK2—psoriasis	4.7e-05	0.000442	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—SOCS1—psoriasis	4.58e-05	0.000431	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—SOCS1—psoriasis	4.58e-05	0.000431	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—VEGFA—psoriasis	4.54e-05	0.000427	CbGpPWpGaD
Yohimbine—HTR2B—GPCR downstream signaling—CXCL8—psoriasis	4.5e-05	0.000424	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—CXCL8—psoriasis	4.45e-05	0.000418	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—CAT—psoriasis	4.39e-05	0.000413	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—TYK2—psoriasis	4.37e-05	0.000411	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—TYK2—psoriasis	4.37e-05	0.000411	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—CXCL8—psoriasis	4.35e-05	0.00041	CbGpPWpGaD
Yohimbine—DRD3—GPCR downstream signaling—CXCL8—psoriasis	4.19e-05	0.000394	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR downstream signaling—CXCL8—psoriasis	4.19e-05	0.000394	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—SOCS1—psoriasis	4.14e-05	0.000389	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—CXCL8—psoriasis	4.11e-05	0.000387	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—CXCL8—psoriasis	4.09e-05	0.000385	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—SOCS1—psoriasis	3.99e-05	0.000376	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—SOCS1—psoriasis	3.97e-05	0.000374	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—APOE—psoriasis	3.95e-05	0.000372	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—LEP—psoriasis	3.95e-05	0.000372	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—TYK2—psoriasis	3.94e-05	0.000371	CbGpPWpGaD
Yohimbine—HTR1F—Signaling by GPCR—IL6—psoriasis	3.9e-05	0.000368	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—LEP—psoriasis	3.87e-05	0.000364	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—APOE—psoriasis	3.87e-05	0.000364	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—SOCS1—psoriasis	3.86e-05	0.000364	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—JUN—psoriasis	3.82e-05	0.000359	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—TYK2—psoriasis	3.81e-05	0.000358	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—CXCL8—psoriasis	3.8e-05	0.000358	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—CXCL8—psoriasis	3.8e-05	0.000358	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—SOCS1—psoriasis	3.8e-05	0.000358	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—TYK2—psoriasis	3.79e-05	0.000357	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	3.78e-05	0.000356	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CARM1—psoriasis	3.78e-05	0.000356	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—VEGFA—psoriasis	3.69e-05	0.000347	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—TYK2—psoriasis	3.68e-05	0.000347	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—NFKBIA—psoriasis	3.68e-05	0.000347	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—NFKB1—psoriasis	3.67e-05	0.000346	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—TP53—psoriasis	3.67e-05	0.000346	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	3.65e-05	0.000344	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—LEP—psoriasis	3.63e-05	0.000342	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—APOE—psoriasis	3.63e-05	0.000342	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	3.63e-05	0.000342	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—TYK2—psoriasis	3.63e-05	0.000341	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—NFKBIA—psoriasis	3.61e-05	0.000339	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CAT—psoriasis	3.57e-05	0.000336	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	3.53e-05	0.000333	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—SOCS1—psoriasis	3.51e-05	0.00033	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	3.48e-05	0.000327	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—SOCS1—psoriasis	3.45e-05	0.000325	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	3.43e-05	0.000323	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—TP53—psoriasis	3.43e-05	0.000323	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—APOE—psoriasis	3.41e-05	0.000321	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—NFKBIA—psoriasis	3.39e-05	0.000319	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—APOE—psoriasis	3.38e-05	0.000318	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—APOE—psoriasis	3.38e-05	0.000318	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—LEP—psoriasis	3.38e-05	0.000318	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—LEP—psoriasis	3.38e-05	0.000318	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—TYK2—psoriasis	3.34e-05	0.000315	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—VEGFA—psoriasis	3.34e-05	0.000314	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	3.32e-05	0.000312	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—STAT3—psoriasis	3.3e-05	0.000311	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	3.3e-05	0.00031	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—TYK2—psoriasis	3.29e-05	0.00031	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	3.21e-05	0.000302	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	3.21e-05	0.000302	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	3.16e-05	0.000297	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	3.15e-05	0.000297	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—NFKBIA—psoriasis	3.15e-05	0.000297	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	3.15e-05	0.000297	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	3.14e-05	0.000295	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—LEP—psoriasis	3.05e-05	0.000287	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—APOE—psoriasis	3.05e-05	0.000287	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TYK2—psoriasis	3.02e-05	0.000284	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	2.99e-05	0.000282	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PPARG—psoriasis	2.97e-05	0.00028	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TYK2—psoriasis	2.95e-05	0.000278	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—LEP—psoriasis	2.95e-05	0.000277	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—APOE—psoriasis	2.95e-05	0.000277	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—APOE—psoriasis	2.93e-05	0.000276	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—LEP—psoriasis	2.93e-05	0.000276	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—CXCL8—psoriasis	2.91e-05	0.000274	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	2.87e-05	0.00027	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	2.86e-05	0.00027	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—APOE—psoriasis	2.85e-05	0.000268	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—LEP—psoriasis	2.85e-05	0.000268	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	2.85e-05	0.000268	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—APOE—psoriasis	2.81e-05	0.000264	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—LEP—psoriasis	2.81e-05	0.000264	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—TP53—psoriasis	2.79e-05	0.000262	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TYK2—psoriasis	2.77e-05	0.000261	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—APOE—psoriasis	2.77e-05	0.000261	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	2.75e-05	0.000259	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	2.73e-05	0.000257	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	2.66e-05	0.00025	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CXCL8—psoriasis	2.63e-05	0.000247	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	2.62e-05	0.000246	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	2.61e-05	0.000245	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—APOE—psoriasis	2.59e-05	0.000244	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—LEP—psoriasis	2.59e-05	0.000244	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TYK2—psoriasis	2.58e-05	0.000243	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TYK2—psoriasis	2.58e-05	0.000243	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CXCL8—psoriasis	2.57e-05	0.000242	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—LEP—psoriasis	2.55e-05	0.00024	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—APOE—psoriasis	2.55e-05	0.00024	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—TP53—psoriasis	2.52e-05	0.000237	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—IL6—psoriasis	2.5e-05	0.000235	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CARM1—psoriasis	2.47e-05	0.000232	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—IL6—psoriasis	2.44e-05	0.00023	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—JUN—psoriasis	2.44e-05	0.00023	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CXCL8—psoriasis	2.42e-05	0.000227	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PPARG—psoriasis	2.41e-05	0.000227	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—NFKBIA—psoriasis	2.41e-05	0.000227	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—JUN—psoriasis	2.39e-05	0.000225	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	2.37e-05	0.000223	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—NFKB1—psoriasis	2.35e-05	0.000221	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TYK2—psoriasis	2.33e-05	0.000219	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CAT—psoriasis	2.32e-05	0.000219	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—LEP—psoriasis	2.32e-05	0.000218	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—APOE—psoriasis	2.32e-05	0.000218	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—IL6—psoriasis	2.31e-05	0.000217	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—NFKB1—psoriasis	2.3e-05	0.000217	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—IL6—psoriasis	2.3e-05	0.000216	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TYK2—psoriasis	2.25e-05	0.000212	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CXCL8—psoriasis	2.25e-05	0.000212	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CXCL8—psoriasis	2.25e-05	0.000212	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—JUN—psoriasis	2.25e-05	0.000211	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TYK2—psoriasis	2.24e-05	0.000211	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TYK2—psoriasis	2.18e-05	0.000205	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—NFKB1—psoriasis	2.16e-05	0.000203	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	2.16e-05	0.000203	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TYK2—psoriasis	2.14e-05	0.000202	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—IL6—psoriasis	2.14e-05	0.000201	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—IL6—psoriasis	2.14e-05	0.000201	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—VEGFA—psoriasis	2.13e-05	0.000201	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—STAT3—psoriasis	2.11e-05	0.000199	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—JUN—psoriasis	2.09e-05	0.000197	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—JUN—psoriasis	2.09e-05	0.000197	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—VEGFA—psoriasis	2.09e-05	0.000197	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—STAT3—psoriasis	2.07e-05	0.000195	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CXCL8—psoriasis	2.03e-05	0.000191	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—NFKB1—psoriasis	2.01e-05	0.000189	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—NFKB1—psoriasis	2.01e-05	0.000189	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TYK2—psoriasis	1.98e-05	0.000186	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—VEGFA—psoriasis	1.96e-05	0.000185	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CXCL8—psoriasis	1.96e-05	0.000184	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CXCL8—psoriasis	1.95e-05	0.000183	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TYK2—psoriasis	1.94e-05	0.000183	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—STAT3—psoriasis	1.94e-05	0.000183	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—IL6—psoriasis	1.93e-05	0.000182	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CXCL8—psoriasis	1.9e-05	0.000178	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—JUN—psoriasis	1.89e-05	0.000178	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	1.87e-05	0.000176	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—IL6—psoriasis	1.86e-05	0.000175	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—IL6—psoriasis	1.85e-05	0.000174	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—VEGFA—psoriasis	1.83e-05	0.000172	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—VEGFA—psoriasis	1.83e-05	0.000172	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—JUN—psoriasis	1.82e-05	0.000171	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—NFKB1—psoriasis	1.82e-05	0.000171	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—JUN—psoriasis	1.81e-05	0.000171	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—STAT3—psoriasis	1.81e-05	0.00017	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—STAT3—psoriasis	1.81e-05	0.00017	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—APOE—psoriasis	1.81e-05	0.00017	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—IL6—psoriasis	1.8e-05	0.00017	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—IL6—psoriasis	1.77e-05	0.000167	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TYK2—psoriasis	1.77e-05	0.000166	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—JUN—psoriasis	1.76e-05	0.000166	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—NFKB1—psoriasis	1.75e-05	0.000165	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—NFKB1—psoriasis	1.74e-05	0.000164	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—JUN—psoriasis	1.73e-05	0.000163	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CXCL8—psoriasis	1.72e-05	0.000162	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—NFKB1—psoriasis	1.7e-05	0.00016	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CXCL8—psoriasis	1.69e-05	0.000159	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	1.67e-05	0.000157	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—VEGFA—psoriasis	1.65e-05	0.000155	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—IL6—psoriasis	1.64e-05	0.000154	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—STAT3—psoriasis	1.63e-05	0.000154	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TP53—psoriasis	1.61e-05	0.000152	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—IL6—psoriasis	1.61e-05	0.000151	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—JUN—psoriasis	1.6e-05	0.00015	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—VEGFA—psoriasis	1.59e-05	0.00015	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—VEGFA—psoriasis	1.58e-05	0.000149	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TP53—psoriasis	1.58e-05	0.000149	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—STAT3—psoriasis	1.58e-05	0.000148	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—JUN—psoriasis	1.57e-05	0.000148	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PPARG—psoriasis	1.57e-05	0.000148	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—STAT3—psoriasis	1.57e-05	0.000148	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	1.54e-05	0.000145	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—VEGFA—psoriasis	1.54e-05	0.000145	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—NFKB1—psoriasis	1.54e-05	0.000145	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—STAT3—psoriasis	1.52e-05	0.000143	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CAT—psoriasis	1.52e-05	0.000143	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	1.52e-05	0.000143	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—NFKB1—psoriasis	1.51e-05	0.000143	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—STAT3—psoriasis	1.5e-05	0.000141	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TP53—psoriasis	1.48e-05	0.00014	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—IL6—psoriasis	1.48e-05	0.000139	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—IL6—psoriasis	1.46e-05	0.000138	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—IL6—psoriasis	1.44e-05	0.000136	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—JUN—psoriasis	1.43e-05	0.000135	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—VEGFA—psoriasis	1.4e-05	0.000131	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—STAT3—psoriasis	1.38e-05	0.00013	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TP53—psoriasis	1.38e-05	0.00013	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TP53—psoriasis	1.38e-05	0.00013	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	1.38e-05	0.00013	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—VEGFA—psoriasis	1.37e-05	0.000129	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—STAT3—psoriasis	1.36e-05	0.000128	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IL6—psoriasis	1.36e-05	0.000128	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IL6—psoriasis	1.26e-05	0.000119	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IL6—psoriasis	1.26e-05	0.000119	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	1.25e-05	0.000118	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TP53—psoriasis	1.25e-05	0.000117	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—STAT3—psoriasis	1.24e-05	0.000117	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TP53—psoriasis	1.2e-05	0.000113	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TP53—psoriasis	1.2e-05	0.000113	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—APOE—psoriasis	1.18e-05	0.000111	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TP53—psoriasis	1.16e-05	0.000109	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TP53—psoriasis	1.14e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL6—psoriasis	1.14e-05	0.000107	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL6—psoriasis	1.1e-05	0.000104	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL6—psoriasis	1.09e-05	0.000103	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL6—psoriasis	1.06e-05	0.0001	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TP53—psoriasis	1.06e-05	9.93e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL6—psoriasis	1.05e-05	9.86e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TP53—psoriasis	1.04e-05	9.77e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PPARG—psoriasis	1.03e-05	9.68e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL6—psoriasis	9.66e-06	9.09e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL6—psoriasis	9.51e-06	8.95e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TP53—psoriasis	9.45e-06	8.89e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL6—psoriasis	8.65e-06	8.14e-05	CbGpPWpGaD
